Madrigal Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:YDO1 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Mar 25	Sell€368,534	Mardi Dier	Individual	1,187	€310.48
28 Feb 25	Sell€402,209	Robert Waltermire	Individual	1,227	€328.26
24 Jan 25	Sell€32,841	Robert Waltermire	Individual	103	€318.85
24 Jan 25	Sell€206,613	Rebecca Taub	Individual	648	€318.85
24 Jan 25	Sell€505,053	William Sibold	Individual	1,584	€318.85
24 Jan 25	Sell€110,640	Carole Huntsman	Individual	347	€318.85
17 Jan 25	Sell€117,427	Robert Waltermire	Individual	442	€265.67
17 Jan 25	Sell€448,721	Rebecca Taub	Individual	1,689	€265.67
17 Jan 25	Sell€73,591	Shannon Kelley	Individual	277	€265.67
03 Dec 24	Sell€1,079,841	The Craves Family Foundation., Endowment Arm	Company	3,600	€300.52
25 Nov 24	Sell€1,136,122	The Craves Family Foundation., Endowment Arm	Company	3,400	€334.55
21 Nov 24	Sell€207,858	Carole Huntsman	Individual	688	€302.12
09 Sep 24	Sell€1,405,185	William Sibold	Individual	6,363	€220.84

Insider Trading Volume

Insider Buying: YDO1 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of YDO1?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	836,727	3.25%
Individual Insiders	1,098,536	4.27%
Hedge Funds	8,090,022	31.4%
Institutions	15,724,630	61.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 91.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.93%	Janus Henderson Group plc	2,205,849	€569.8m	-0.12%	0.26%
9.46%	Paulson & Co. Inc.	2,099,523	€542.4m	2.82%	21.67%
9.11%	Avoro Capital Advisors LLC	2,022,222	€522.4m	-0.33%	9.42%
8.98%	RTW Investments, LP	1,993,687	€515.0m	0%	8.8%
8.89%	Baker Bros. Advisors LP	1,974,590	€510.1m	0%	4.71%
7.61%	The Vanguard Group, Inc.	1,690,111	€436.6m	-0.94%	0.01%
6.69%	BlackRock, Inc.	1,486,459	€384.0m	-0.52%	0.01%
3.42%	State Street Global Advisors, Inc.	758,511	€195.9m	-2.92%	0.01%
2.95%	SQN, LLC	655,540	€169.3m	0%	no data
2.94%	FMR LLC	651,901	€168.4m	-24.9%	0.01%
2.44%	T. Rowe Price Group, Inc.	542,633	€140.2m	-7.84%	0.01%
1.99%	Rebecca Taub	442,323	€114.3m	0%	no data
1.93%	Frederick Craves	429,004	€110.8m	19%	no data
1.9%	Geode Capital Management, LLC	420,875	€108.7m	2.51%	0.01%
1.76%	Holocene Advisors, LP	390,545	€100.9m	0%	0.32%
1.6%	William Blair Investment Management, LLC	354,158	€91.5m	-4.74%	0.13%
1.55%	Morgan Stanley, Investment Banking and Brokerage Investments	344,489	€89.0m	90.8%	0.01%
1.45%	UBS Asset Management AG	321,507	€83.1m	-8.87%	0.01%
1.43%	Woodline Partners LP	317,433	€82.0m	2.69%	0.58%
1.1%	Hood River Capital Management LLC	243,994	€63.0m	90.9%	1.11%
0.93%	Pictet Asset Management Limited	207,043	€53.5m	-0.69%	0.04%
0.86%	Adage Capital Management, L.P.	191,609	€49.5m	860%	0.1%
0.82%	667, L.P.	181,187	€46.8m	0%	no data
0.81%	ArrowMark Colorado Holdings, LLC	180,109	€46.5m	-9.8%	0.81%
0.75%	Rock Springs Capital Management LP	166,698	€43.1m	-37.2%	2.79%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/21 15:31
End of Day Share Price	2025/05/20 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Madrigal Pharmaceuticals, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Matthew Luchini	BMO Capital Markets Equity Research
Jason Zemansky	BofA Global Research
Alexandria Hammond	BofA Global Research